People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.
Toronto-based biotechnology company Awakn has a research program on ketamine-assisted psychotherapy against multiple addictions.
Vancouver biotechnology company Havn Life will export yield to UBC-based Delic Labs for quality control and testing.
Petter Grahl Johnstad of the University of Bergen says a bad psychedelics trip can be a way to confront personal demons.
A study in Argentina finds association between the use of psychedelic substances with positive mental health outcomes.
The new Braxia Health clinic represents the company’s fourth ketamine facility in Canada.
Researchers from The Netherlands, U.S. and U.K. conducted a study with 452 respondents who have used mescaline.
The Vancouver-based BetterLife Pharma Inc. develops psychedelic products and delivery systems.
A new study shows that ayahuasca offers an option in dealing with depression